View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.
Authors: Östör, Andrew1,2,3,4 (AUTHOR) andrewostor@gmail.com, Van den Bosch, Filip5,6 (AUTHOR), Papp, Kim7,8 (AUTHOR), Keiserman, Mauro9 (AUTHOR), Blanco, Ricardo10 (AUTHOR), Crowley, Angela11 (AUTHOR), White, Douglas12,13 (AUTHOR), Biljan, Ana14 (AUTHOR), Madihlaba, Tshepiso14 (AUTHOR), Carter, Kyle14 (AUTHOR), Liu, Fang14 (AUTHOR), Soliman, Ahmed M.14 (AUTHOR), Ashley, Doug14 (AUTHOR), Chen, Michael14 (AUTHOR), Glotfelty, Lila14 (AUTHOR), Kivitz, Alan15 (AUTHOR)
Source: Rheumatology & Therapy. Dec2025, Vol. 12 Issue 6, p1103-1123. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189534296
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Östör%2C+Andrew%22">Östör, Andrew</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<i> andrewostor@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Van+den+Bosch%2C+Filip%22">Van den Bosch, Filip</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Papp%2C+Kim%22">Papp, Kim</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keiserman%2C+Mauro%22">Keiserman, Mauro</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blanco%2C+Ricardo%22">Blanco, Ricardo</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crowley%2C+Angela%22">Crowley, Angela</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22White%2C+Douglas%22">White, Douglas</searchLink><relatesTo>12,13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Biljan%2C+Ana%22">Biljan, Ana</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Madihlaba%2C+Tshepiso%22">Madihlaba, Tshepiso</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carter%2C+Kyle%22">Carter, Kyle</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Fang%22">Liu, Fang</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Soliman%2C+Ahmed+M%2E%22">Soliman, Ahmed M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ashley%2C+Doug%22">Ashley, Doug</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Michael%22">Chen, Michael</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glotfelty%2C+Lila%22">Glotfelty, Lila</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kivitz%2C+Alan%22">Kivitz, Alan</searchLink><relatesTo>15</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Rheumatology+%26+Therapy%22">Rheumatology & Therapy</searchLink>. Dec2025, Vol. 12 Issue 6, p1103-1123. 21p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189534296
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40744-025-00793-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 21
        StartPage: 1103
    Titles:
      – TitleFull: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Östör, Andrew
      – PersonEntity:
          Name:
            NameFull: Van den Bosch, Filip
      – PersonEntity:
          Name:
            NameFull: Papp, Kim
      – PersonEntity:
          Name:
            NameFull: Keiserman, Mauro
      – PersonEntity:
          Name:
            NameFull: Blanco, Ricardo
      – PersonEntity:
          Name:
            NameFull: Crowley, Angela
      – PersonEntity:
          Name:
            NameFull: White, Douglas
      – PersonEntity:
          Name:
            NameFull: Biljan, Ana
      – PersonEntity:
          Name:
            NameFull: Madihlaba, Tshepiso
      – PersonEntity:
          Name:
            NameFull: Carter, Kyle
      – PersonEntity:
          Name:
            NameFull: Liu, Fang
      – PersonEntity:
          Name:
            NameFull: Soliman, Ahmed M.
      – PersonEntity:
          Name:
            NameFull: Ashley, Doug
      – PersonEntity:
          Name:
            NameFull: Chen, Michael
      – PersonEntity:
          Name:
            NameFull: Glotfelty, Lila
      – PersonEntity:
          Name:
            NameFull: Kivitz, Alan
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 21986576
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Rheumatology & Therapy
              Type: main
ResultId 1